-
J.P. Morgan Reiterates Neutral on Stryker
Wednesday, July 20, 2011 - 8:12am | 108J.P. Morgan is out with its report today on Stryker (NYSE: SYK), reiterating Neutral. In a note to clients, J.P. Morgan writes, "Stryker reported a 2Q result that was mostly in line, with sales of $2,046M (+16.3%, +5.7% organic) coming in about $40M above Street consensus, reflecting a...
-
UPDATE: Jefferies Lowers PT on Gen-Probe to $75
Wednesday, July 20, 2011 - 7:57am | 115Jefferies is out with its report today on, Gen-Probe (NASDAQ: GPRO), lowering its PT from $92 to $75. In a note to clients, Jefferies writes, "According to media reports, NVS is no longer actively pursuing an acquisition of GPRO. Although we remain in denial, as the concept that a well-capitalized...
-
Piper Jaffray Upgrades GPRO to Overweight
Wednesday, July 20, 2011 - 7:51am | 93Piper Jaffray has issued a report upgrading Gen-Probe (NASDAQ: GPRO) from Neutral to Overweight. According to the report, "Yesterday, the Wall Street Journal published an article describing Novartis' withdrawal from Gen-Probe takeover discussions, reportedly removing the last remaining bidder and...
-
Morgan Stanley Reiterates Overweight on SYK
Wednesday, July 20, 2011 - 7:34am | 66Morgan Stanley has issued a report maintaining an Overweight Rating on Stryker Corporation (NYSE: SYK). According to the report, "In total, SYK reported an in-line quarter and maintained guidance, and our thesis remains intact. Gross margins, MedSurg performance and to a lesser extent taxes...
-
JP Morgan Raises PT On Intuitive Surgical To $350
Wednesday, July 20, 2011 - 7:33am | 27JP Morgan has raised the price target on Intuitive Surgical (NASDAQ: ISRG) from $325 to $350 and maintains its Neutral rating.
-
UPDATE: Morgan Keegan Raising Price Target On Intuitive Surgical Corporation
Wednesday, July 20, 2011 - 7:33am | 178Morgan Keegan is out with a research report on Intuitive Surgical Corporation (NASDAQ: ISRG) after the company reported earnings last night. The price target was raised to $385, and it has a Market Perform rating on shares. In a note to clients, Morgan Keegan writes, "Intuitive Surgical reported...
-
UPDATE: Bank of America Merrill Lynch Raises PO on Intuitive Surgical to $385
Wednesday, July 20, 2011 - 7:21am | 133Bank of America Merrill Lynch is out with its report today on Intuitive Surgical (NASDAQ: ISRG), raising its PO from $365 to $385. In a note to clients, Bank of America Merrill Lynch writes, "We are raising our 2011-2012 revenue estimates for ISRG to $1,692mm and $1,996mm respectively or 20% and...
-
Morgan Stanley Raises ISRG Guidance
Wednesday, July 20, 2011 - 7:19am | 73Morgan Stanley has issued a report raising its guidance for Intuitive Surgical (NASDAQ: ISRG) following its strong quarter results. According to the report, "Intuitive adjusted its 2011 annual guidance, reflecting outperformance vs. expectations in 1H11. Positive adjustments for revenue, procedure...
-
Goldman Sachs Removes ISRG from Americas Sell List
Wednesday, July 20, 2011 - 7:09am | 82Goldman Sachs has issued a report that Intuitive Surgical (NASDAQ: ISRG) has been removed from Americas Sell List and upgraded to a Neutral Rating. Goldman Sachs writes, "Following strong 2Q2011 results, evidence has emerged that the company has more potential longterm growth drivers (namely new...
-
Bank of America Merrill Lynch Reports SYK Top Line Strong
Wednesday, July 20, 2011 - 7:06am | 89Bank of America Merrill Lynch has released a report this morning on Stryker Corp's (NYSE: SYK) strong top line. According to the report, "SYK reported a 200 bp sequential acceleration in organic constant currency top line growth during Q2 to just under 6% growth up from 4% in Q1. There were some...
-
Wunderlich Securities Reiterates Hold and PT of $56 on Stryker
Wednesday, July 20, 2011 - 7:02am | 62Wunderlich Securities reiterated its Hold rating on Stryker (NYSE: SYK). At the same time, the rating agency left its price target on the company's stock unchanged at $56. On Tuesday, SYK added 1.54% to its value to finish the day at $59.16. Its shares lost all of yesterday's gains in today's pre-...
-
Jefferies Lowers PT On Gen-Probe To $75
Wednesday, July 20, 2011 - 6:41am | 26Jefferies & Company has lowered the price target on Gen-Probe (NASDAQ: GPRO) from $92 to $75 and maintains its Buy rating.
-
Piper Jaffray Upgrades Gen-Probe To Overweight, $78 PT
Wednesday, July 20, 2011 - 6:34am | 23Piper Jaffray has upgraded Gen-Probe (NASDAQ: GPRO) from Neutral to Overweight with a $78 price target.
-
Jefferies Lowers PT On Stryker To $66
Wednesday, July 20, 2011 - 6:29am | 26Jefferies & Company has lowered the price target on Stryker (NYSE: SYK) from $70 to $66 and maintains its Hold rating.
-
Morgan Keegan Raises PT On Intuitive Surgical Corporation To $385
Wednesday, July 20, 2011 - 6:26am | 28Morgan Keegan has raised the price target on Intuitive Surgical (NASDAQ: ISRG) from $345 to $385 and maintains its Market Perform rating.